- Home
- APVO vs CREG Comparison
APVO vs CREG Comparison
Compare APVO & CREG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- CREG
- Stock Information
- Founded
- APVO 2016
- CREG N/A
- Country
- APVO United States
- CREG China
- Employees
- APVO N/A
- CREG N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- CREG Power Generation
- Sector
- APVO Health Care
- CREG Utilities
- Exchange
- APVO Nasdaq
- CREG Nasdaq
- Market Cap
- APVO 4.9M
- CREG 4.7M
- IPO Year
- APVO N/A
- CREG N/A
- Fundamental
- Price
- APVO $1.57
- CREG $1.59
- Analyst Decision
- APVO Strong Buy
- CREG
- Analyst Count
- APVO 1
- CREG 0
- Target Price
- APVO $5,920.00
- CREG N/A
- AVG Volume (30 Days)
- APVO 176.9K
- CREG 256.6K
- Earning Date
- APVO 11-06-2025
- CREG 11-07-2025
- Dividend Yield
- APVO N/A
- CREG N/A
- EPS Growth
- APVO N/A
- CREG N/A
- EPS
- APVO N/A
- CREG N/A
- Revenue
- APVO N/A
- CREG $82,839.00
- Revenue This Year
- APVO N/A
- CREG N/A
- Revenue Next Year
- APVO N/A
- CREG N/A
- P/E Ratio
- APVO N/A
- CREG N/A
- Revenue Growth
- APVO N/A
- CREG N/A
- 52 Week Low
- APVO $1.41
- CREG $1.11
- 52 Week High
- APVO $381.10
- CREG $14.70
- Technical
- Relative Strength Index (RSI)
- APVO 47.04
- CREG 49.68
- Support Level
- APVO N/A
- CREG $1.47
- Resistance Level
- APVO $1.54
- CREG $1.67
- Average True Range (ATR)
- APVO 0.18
- CREG 0.17
- MACD
- APVO -0.02
- CREG 0.05
- Stochastic Oscillator
- APVO 57.55
- CREG 51.79
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.